| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 48.3 | 40.8 |
| Gross profit | 22.4 | 18.6 |
| Profit before tax | -2.2 | -2.9 |
| Net income | -2.1 | -2.7 |
| EPS (diluted, $ a share) | $-0.03 | $-0.04 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Revenue, year on year | +18.4% |
|---|---|
| Gross margin | 46.4% |
| Operating margin | -4.5% |
10-Q filed with the SEC, NYSE: ZVIA. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Zevia PBC: key numbers
- Share price
- $1.00Close, Nov 16
- Sector
- Manufacturing
- Industry
- Bottled & Canned Soft Drinks & Carbonated WatersSIC 2086
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Zevia PBC
All →Zevia PBC President & CEO Alexandre Ruberti Buys $99.9K of Stock
Alexandre Ruberti, President & CEO, bought 81,300 shares of Zevia PBC at $1.23 a share, worth $99.9K in total on Nov 9, 2026. Shares held after the trade: 1,295,710 (+6.7%).
- Value
- $99.9K
- Shares
- 81,300
- Price
- $1.23
- Role
- President & CEO
- Holding change
- +6.7%
- Trade date
- Nov 9, 2026
Zevia PBC Director David J. Lee Sells $231K of Stock
David J. Lee, Director, sold 179,589 shares of Zevia PBC at $1.29 a share, worth $231K in total on Nov 9, 2026. Shares held after the trade: 100,373 (-64.1%).
- Value
- $231K
- Shares
- 179,589
- Price
- $1.29
- Role
- Director
- Holding change
- -64.1%
- Trade date
- Nov 9, 2026
Zevia PBC Director Padraic L. Spence Sells $213K of Stock
Padraic L. Spence, Director, sold 180,000 shares of Zevia PBC at $1.18 to $1.26 a share (average $1.18) in 2 transactions, worth $213K in total between Nov 9, 2026 and Nov 10, 2026. Shares held after the trade: 1,447,881 (-10.4%).
- Value
- $213K
- Shares
- 180,000
- Average price
- $1.18
- Role
- Director
- Holding change
- -10.4%
- Trade date
- Nov 9, 2026 to Nov 10, 2026
Zevia PBC Earnings Call: Key Takeaways
Zevia delivered strong 18.4% Q3 revenue growth and secured a $20 million equity investment to pivot toward functional beverages and digital-first marketing.
- Call
- Nov 4, 2026, 4:30 PM ET
Zevia PBC Financial Results
Zevia PBC reported Q3 2026 financial results with net sales growing 18.4% year-over-year to $48.3 million, exceeding its previous guidance. The company improved its net loss to $2.2 million and raised its full-year 2026 outlook for both net sales and Adjusted EBITDA.
- Term
- Q3 2026
“Our better-than-expected third quarter results, combined with strong execution against our key focus areas and encouraging proof points across the business, reinforce our confidence in Zevia’s trajectory. With a stronger foundation, significant liquidity and additional capital, we are entering an exciting new chapter for our business. We believe we now have the resources, momentum and strategic plan to accelerate our growth and create shareholder value over the long term.”
Alexandre Ruberti, President and CEO of Zevia
Zevia PBC Capital Raise of $15M
Zevia PBC entered into a securities purchase agreement with Bubble Holdings, LLC (an affiliate of GP Investments, Ltd.) to raise up to $20 million through the issuance of Series A Senior Convertible Preferred Stock. The company completed an initial closing of $15 million on October 22, 2026, with a deferred closing of $5 million contingent on meeting specific 2026 net sales and Adjusted EBITDA targets.
- Value
- $15M
- Counterparty
- Bubble Holdings, LLC
“This growth equity investment marks an important milestone in Zevia’s evolution and provides the capital, strategic resources, and operational expertise to accelerate our medium- and long-term growth agenda.”
Alexandre Ruberti, Zevia’s Chief Executive Officer
“We are thrilled to partner with Zevia and help support accelerated profitable growth. The team’s execution strengths and clear growth plan give us confidence in Zevia’s potential to become a leading everyday alternative to traditional soda, as consumers increasingly seek healthier options without artificial sweeteners.”
Rodrigo Boscolo, CEO of GP Investments